Allan S. Jaffe,
#83,615
Most Influential Person Now
Allan S. Jaffe,'s AcademicInfluence.com Rankings
Allan S. Jaffe,medical Degrees
Medical
#792
World Rank
#1040
Historical Rank
Cardiology
#37
World Rank
#37
Historical Rank
Download Badge
Medical
Why Is Allan S. Jaffe, Influential?
(Suggest an Edit or Addition)Allan S. Jaffe,'s Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (4196)
- Third universal definition of myocardial infarction. (2012) (4123)
- Third universal definition of myocardial infarction (2012) (3338)
- Fourth Universal Definition of Myocardial Infarction (2018). (2018) (2724)
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (2339)
- 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (2334)
- Universal definition of myocardial infarction. (2015) (2234)
- Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. (2003) (1823)
- Fourth universal definition of myocardial infarction (2018). (2018) (1537)
- Cardiac Troponin I A Marker With High Specificity for Cardiac Injury (1993) (1205)
- Analytical validation of a high-sensitivity cardiac troponin T assay. (2010) (991)
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) (941)
- Third universal definition of myocardial infarction. (2012) (921)
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association (2014) (839)
- Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. (2002) (768)
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase (1988) (764)
- Third universal definition of myocardial infarction. (2012) (751)
- Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. (2004) (748)
- Biomarkers in acute cardiac disease: the present and the future. (2006) (663)
- It's time for a change to a troponin standard. (2000) (652)
- Recommendations for the use of cardiac troponin measurement in acute cardiac care. (2010) (619)
- Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. (2004) (617)
- Biochemical Markers of Myocardial Injury Is MB Creatine Kinase the Choice for the 1990s? (1993) (605)
- Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination (2002) (595)
- Risk factors for sudden death after acute myocardial infarction: two-year follow-up. (1984) (563)
- Troponin: the biomarker of choice for the detection of cardiac injury (2005) (549)
- Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. (1994) (546)
- Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. (1997) (536)
- The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis☆ (1989) (527)
- Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. (2008) (507)
- Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery (2017) (499)
- How to use high-sensitivity cardiac troponins in acute cardiac care (2012) (484)
- Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. (2005) (467)
- Association of depression witk reduced heart rate variability in coronary artery disease (1995) (439)
- Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. (1987) (436)
- Fourth Universal Definition of Myocardial Infarction (2018). (2018) (429)
- Prevalence of Depression in Hospitalized Patients With Congestive Heart Failure (2003) (418)
- Third universal definition of myocardial infarction. (2012) (408)
- Improving survival from sudden cardiac arrest (1991) (402)
- Insulin Independence After Islet Transplantation Into Type I Diabetic Patient (1990) (402)
- European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. (2002) (400)
- Major depressive disorder in coronary artery disease. (1987) (380)
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. (2007) (376)
- Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. (1988) (375)
- Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients (1984) (373)
- The quantification of infarct size. (2004) (368)
- Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. (2011) (355)
- Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for ST-Elevation Myocardial Infarction: The Mayo Clinic STEMI Protocol (2007) (353)
- How to use high-sensitivity cardiac troponins in acute cardiac care. (2013) (345)
- Multicenter analytical evaluation of a high-sensitivity troponin T assay. (2011) (338)
- Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. (1994) (337)
- Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. (1997) (337)
- Major depression and medication adherence in elderly patients with coronary artery disease. (1995) (330)
- Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial Infarction (2010) (327)
- Change in Heart Rate and Heart Rate Variability During Treatment for Depression in Patients With Coronary Heart Disease (2000) (327)
- Myocardial injury in critically ill patients. A frequently unrecognized complication. (1995) (320)
- Diastolic dysfunction and mortality in severe sepsis and septic shock. (2012) (315)
- Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. (2005) (308)
- Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. (2004) (303)
- What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey. (2013) (301)
- Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. (2012) (288)
- Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. (2000) (283)
- Association of depression with reduced heart rate variability in coronary artery disease. (1995) (281)
- Perioperative Myocardial Infarction (2009) (279)
- Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. (2013) (279)
- Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins (2003) (277)
- Depression and Late Mortality After Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study (2004) (276)
- Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care. (2017) (270)
- Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. (2000) (270)
- Depression as a risk factor for cardiac events in established coronary heart disease: A review of possible mechanisms (1995) (266)
- Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. (1984) (264)
- Cardiac Troponin for Assessment of Myocardial Injury in COVID-19 (2020) (259)
- Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. (1988) (255)
- National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. (2007) (255)
- Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. (2011) (252)
- Depression as a risk factor for mortality after acute myocardial infarction. (2003) (239)
- Bedside Multimarker Testing for Risk Stratification in Chest Pain Units: The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study (2001) (231)
- A randomised study (2003) (226)
- Paradoxic elevation of fibrinopeptide A after streptokinase: evidence for continued thrombosis despite intense fibrinolysis. (1987) (226)
- Improved detection of cardiac contusion with cardiac troponin I. (1996) (220)
- IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. (2015) (218)
- Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction (2005) (217)
- Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. (2006) (217)
- Determinants of hemodynamic compromise with severe right ventricular infarction. (1990) (214)
- Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection: A Collaborative Meta-analysis. (2017) (214)
- Major Depression and Medication Adherence in Elderly Patients With Coronary Artery Disease (1995) (212)
- Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. (1996) (208)
- High-sensitive troponin T measurements: what do we gain and what are the challenges? (2012) (207)
- Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis (2007) (206)
- Low heart rate variability and the effect of depression on post-myocardial infarction mortality. (2005) (202)
- Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis (2009) (196)
- Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies (2003) (194)
- Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure: The Importance of Change Over Time (2007) (192)
- Quality specifications for B-type natriuretic peptide assays. (2005) (187)
- Fibrinopeptide A: a marker of acute coronary thrombosis. (1985) (187)
- Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. (2008) (182)
- Troponin Elevation in Severe Sepsis and Septic Shock: The Role of Left Ventricular Diastolic Dysfunction and Right Ventricular Dilatation* (2014) (182)
- The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. (2008) (173)
- Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. (2009) (171)
- How is cardiac troponin released from injured myocardium? (2018) (170)
- B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. (2014) (169)
- Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study Intervention: Rationale and Design (2001) (167)
- Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). (2013) (166)
- Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay. (2010) (163)
- A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. (2020) (162)
- Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. (2006) (159)
- Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention: An Analysis of Preintervention and Postintervention Troponin T Levels in 5487 Patients (2008) (158)
- Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease (1999) (157)
- Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. (1984) (156)
- Type 2 Myocardial Infarction: JACC Review Topic of the Week. (2019) (155)
- High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. (2013) (153)
- Preparing the United States for high-sensitivity cardiac troponin assays. (2013) (152)
- Prolonged exercise decreases serum leptin concentrations. (1997) (152)
- Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. (1993) (152)
- Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients (2008) (150)
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis. (1986) (148)
- Redefinition of Myocardial Infarction: Prospective Evaluation in the Community (2006) (147)
- Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. (2012) (147)
- Cardiac troponin I in pediatrics: normal values and potential use in the assessment of cardiac injury. (1997) (146)
- Fourth Universal Definition of Myocardial Infarction (2018). (2018) (144)
- Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. (2007) (142)
- Sensitive Troponin Assay and the Classification of Myocardial Infarction (2015) (142)
- Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. (2005) (140)
- Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the definition of myocardial infarction. (2010) (140)
- Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. (1986) (139)
- Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. (2013) (136)
- Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. (1990) (136)
- Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. (2008) (133)
- Defining high-sensitivity cardiac troponin concentrations in the community. (2013) (131)
- Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock. (2019) (131)
- Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase. (1984) (129)
- Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. (1984) (129)
- Chasing troponin: how low can you go if you can see the rise? (2006) (128)
- Diagnostic and therapeutic implications of type 2 myocardial infarction: review and commentary. (2014) (123)
- A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination (2015) (123)
- Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. (1992) (119)
- Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction. (1986) (118)
- Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. (1988) (116)
- Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. (2009) (115)
- Thirty-Day Rehospitalizations After Acute Myocardial Infarction (2012) (115)
- Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. (1984) (113)
- Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results. (2013) (112)
- Insomnia and depression prior to myocardial infarction. (1990) (110)
- Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia. (1992) (108)
- Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure (2011) (108)
- The universal definition of myocardial infarction: a consensus document (2007) (107)
- Mitral Valve Prolapse: A Consistent Manifestation of Type IV Ehlers‐Danlos Syndrome The Pathogenetic Role of the Abnormal Production of Type III Collagen (1981) (107)
- Comprehensive standardized data definitions for acute coronary syndrome research in emergency departments in Australasia (2010) (106)
- Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. (2013) (105)
- Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. (2009) (105)
- Variability of biomarkers in patients with chronic heart failure and healthy controls (2016) (102)
- Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. (2001) (102)
- Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. (2005) (101)
- Depression and five year survival following acute myocardial infarction: a prospective study. (2008) (101)
- Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. (2006) (100)
- Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice. (2016) (100)
- Transient right but not left ventricular dysfunction after strenuous exercise at high altitude. (1997) (99)
- Requiem for a Heavyweight: The Demise of Creatine Kinase-MB (2008) (99)
- High-sensitivity cardiac troponin t concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation. (2015) (96)
- Plasma Ceramides: A Novel Predictor of Major Adverse Cardiovascular Events After Coronary Angiography (2018) (94)
- Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. (2004) (93)
- Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. (1997) (92)
- Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. (2012) (92)
- Lipoprotein-Associated Phospholipase A2 and Prognosis After Myocardial Infarction in the Community (2006) (92)
- Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. (2009) (92)
- Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. (1986) (91)
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure. (2007) (85)
- Comparison of conventional and high-sensitivity troponin in patients with chest pain: a collaborative meta-analysis. (2015) (84)
- Major depression in coronary artery disease patients with vs. without a prior history of depression. (1992) (83)
- Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary InterventionCLINICAL PERSPECTIVE (2008) (83)
- Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel. (2019) (82)
- Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism (2004) (82)
- The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. (2006) (81)
- Possible mechanisms behind cardiac troponin elevations (2018) (81)
- History of Depression and Survival After Acute Myocardial Infarction (2009) (81)
- Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. (2009) (80)
- Soluble ST2--analytical considerations. (2015) (80)
- Reduction of infarct size in patients with inferior infarction with intravenous glyceryl trinitrate. A randomised study. (1983) (79)
- Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014. (2019) (78)
- [Fourth universal definition of myocardial infarction (2018)]. (2018) (78)
- Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. (2000) (77)
- Long-term health outcomes associated with detectable troponin I concentrations. (2007) (76)
- Can treating depression reduce mortality after an acute myocardial infarction? (1999) (76)
- Increased creatine kinase MB in the absence of acute myocardial infarction. (1986) (76)
- Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. (2013) (75)
- Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit population. (2019) (74)
- Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods (2002) (74)
- Elevations of cardiac troponin I are associated with increased short-term mortality in noncardiac critically ill emergency department patients. (2002) (73)
- Diagnostic accuracy of clinical prediction rules to exclude acute coronary syndrome in the emergency department setting: a systematic review. (2008) (73)
- Role of Admission Troponin‐T and Serial Troponin‐T Testing in Predicting Outcomes in Severe Sepsis and Septic Shock (2017) (72)
- The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF). (2005) (71)
- Rapid rule out of acute myocardial infarction: novel biomarker-based strategies (2017) (71)
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. (2008) (70)
- Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. (2006) (70)
- What to do when you question cardiac troponin values (2018) (70)
- Elevations in cardiac troponin measurements: False false-positives (2007) (70)
- How to use D-dimer in acute cardiovascular care (2017) (70)
- The 10 commandments of troponin, with special reference to high sensitivity assays (2011) (69)
- Depression as a risk factor for coronary heart disease mortality. (2001) (69)
- Effects of Depression on QT Interval Variability After Myocardial Infarction (2003) (68)
- Sudden death and its relation to QT-interval prolongation after acute myocardial infarction: two-year follow-up. (1986) (68)
- Cardiac troponin levels following monitored epileptic seizures (2003) (68)
- Myocardial Dysfunction in Severe Sepsis and Septic Shock: No Correlation With Inflammatory Cytokines in Real-life Clinical Setting. (2015) (67)
- Letters to the editor Reply (1989) (67)
- Recommended guidelines for in-hospital cardiac monitoring of adults for detection of arrhythmia. Emergency Cardiac Care Committee members. (1991) (67)
- Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. (1983) (67)
- Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. (2007) (66)
- Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. (2014) (66)
- Troponin release--reversible or irreversible injury? Should we care? (2012) (65)
- Prognostic significance of mitral regurgitation in acute myocardial infarction. The MILIS Study Group. (1990) (64)
- Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (A MILIS Study). (1985) (64)
- Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads. (2017) (64)
- B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema* (2006) (64)
- Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction. (2019) (64)
- Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. (1992) (63)
- Plasma MB creatine kinase after vigorous exercise in professional athletes. (1984) (63)
- Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. (2004) (62)
- Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective. (2017) (62)
- 31st Bethesda Conference. Emergency Cardiac Care. Task force 2: Acute coronary syndromes: Section 2B--Chest discomfort evaluation in the hospital. (2000) (60)
- Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. (2007) (60)
- Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000–2014 (2019) (60)
- High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis (2014) (60)
- Right atrial ischemia exacerbates hemodynamic compromise associated with experimental right ventricular dysfunction. (1991) (60)
- Validation of a proposed novel equation for estimating LDL cholesterol. (2014) (59)
- Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure. (2007) (59)
- Weight change after myocardial infarction--the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) experience. (2008) (59)
- Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. (2009) (59)
- Usefulness of detectable levels of troponin, below the 99th percentile of the normal range, as a clue to the presence of underlying coronary artery disease. (2007) (59)
- Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure (2011) (59)
- Survival of Patients on the Kidney Transplant Wait List: Relationship to Cardiac Troponin T (2008) (59)
- A translational approach to detecting drug-induced cardiac injury with cardiac troponins: consensus and recommendations from the Cardiac Troponins Biomarker Working Group of the Health and Environmental Sciences Institute. (2009) (59)
- Implications of "reciprocal" ST segment depression associated with acute myocardial infarction identified by positron tomography. (1983) (59)
- Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department. (2018) (58)
- Interim cardiac safety analysis of NCCTG N9831 Intergroup adjuvant trastuzumab trial (2005) (58)
- Elevated cardiac troponin T levels in critically ill patients with sepsis. (2013) (57)
- Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort (2020) (56)
- Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. (1998) (56)
- Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides. (2017) (56)
- Using high-sensitivity troponin T: the importance of the proper gold standard. (2013) (55)
- Elevated donor cardiac troponin I. A marker of acute graft failure in infant heart recipients. (1994) (55)
- Regional Variation in the Management and Outcomes of Acute Myocardial Infarction With Cardiogenic Shock in the United States (2020) (55)
- Heart Rate Turbulence, Depression, and Survival After Acute Myocardial Infarction (2007) (53)
- Acute coronary syndrome biomarkers: the need for more adequate reporting. (2004) (53)
- Clinical implications of the Third Universal Definition of Myocardial Infarction (2013) (53)
- Temporal trends and outcomes of prolonged invasive mechanical ventilation and tracheostomy use in acute myocardial infarction with cardiogenic shock in the United States. (2019) (53)
- Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding* (2009) (52)
- Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure. (2010) (52)
- Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. (2010) (51)
- Troponin T levels and infarct size by SPECT myocardial perfusion imaging. (2011) (51)
- Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA). (1988) (51)
- Troponin, B‐type natriuretic peptides and outcomes in severe heart failure: Differences between ischemic and dilated cardiomyopathies (2007) (51)
- Cardiac troponin T in obstructive sleep apnea. (2004) (50)
- Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction. (2008) (50)
- How to use C-reactive protein in acute coronary care. (2013) (50)
- Clinical importance of cardiac troponin release and cardiac abnormalities in patients with supratentorial cerebral hemorrhages. (2006) (50)
- Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure. (2005) (50)
- Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome. (2010) (49)
- Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction. (2011) (49)
- Brain natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. (2006) (49)
- Diagnostic application of the universal definition of myocardial infarction in the intensive care unit (2008) (48)
- Lipoprotein-associated phospholipase A2: review and recommendation of a clinical cut point for adults. (2006) (48)
- Relationship between elevated plasma levels of crosslinked fibrin degradation products (XL-FDP) and the clinical presentation of patients with myocardial infarction. (1987) (48)
- Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina. (1991) (48)
- Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock (2019) (48)
- Time Course of Degradation of Cardiac Troponin I in Patients With Acute ST-Elevation Myocardial Infarction: The ASSENT-2 Troponin Substudy (2006) (48)
- Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP (2017) (48)
- Dimensions of Social Support and Depression in Patients at Increased Psychosocial Risk Recovering from Myocardial Infarction (2009) (47)
- Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock (2019) (47)
- Recent changes in management of acute myocardial infarction: implications for emergency care physicians. (1988) (47)
- Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina. (1999) (47)
- Prognostic significance of the treadmill exercise test performance 6 months after myocardial infarction. (1986) (46)
- High-sensitivity cardiac troponin: hype, help, and reality. (2010) (46)
- Early vs. delayed in-hospital cardiac arrest complicating ST-elevation myocardial infarction receiving primary percutaneous coronary intervention. (2019) (45)
- Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus (2010) (45)
- High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population. (2014) (45)
- Catecholamine interference in enzymatic creatinine assays. (2009) (45)
- Clinical cues for detecting ictal asystole (2007) (45)
- Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. (2008) (44)
- Use of copeptin for rapid rule-out of acute myocardial infarction (2018) (44)
- Erratum: Troponin: The biomarker of choice for the detection of cardiac injury (Canadian Medical Association Journal (2005) 173, 10 (1191-1202) DOI: 10.1503/cmaj.050141 (2005) (44)
- Why all the struggle about CK-MB and PCI? (2012) (44)
- Improving Survival From Cardiac Arrest: A Review of Contemporary Practice and Challenges. (2016) (44)
- Cardiac amyloidosis simulating hypertrophic cardiomyopathy. (1984) (44)
- Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. (2009) (43)
- Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction (2010) (43)
- Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. (1990) (43)
- Quantification of myocardial infarction: a comparison of single photon-emission computed tomography with pyrophosphate to serial plasma MB-creatine kinase measurements. (1985) (42)
- Pulmonary artery catheter use in acute myocardial infarction‐cardiogenic shock (2020) (42)
- Monitoring activity of fibrinolytic agents. A therapeutic challenge. (1984) (42)
- Universal MI Definition Update for Cardiovascular Disease (2014) (42)
- Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. (2010) (41)
- Using High-Sensitivity Cardiac Troponin T for Acute Cardiac Care. (2017) (41)
- Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N. (1987) (41)
- Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. (2009) (41)
- A simplified method to predict occurrence of complete heart block during acute myocardial infarction (1986) (40)
- Erdheim-Chester disease with cardiac involvement successfully treated with anakinra. (2013) (40)
- In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association (2014) (40)
- Sex Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction in the Young (2020) (40)
- Soluble ST2 and galectin-3 in pediatric patients without heart failure. (2015) (40)
- Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectoris (2002) (40)
- Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. (2005) (40)
- Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance. (2014) (40)
- Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction. (1979) (40)
- Major depression, panic disorder, and mitral valve prolapse in patients who complain of chest pain. (1990) (40)
- Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation. (2001) (39)
- Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. (2008) (39)
- Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI) (2021) (39)
- Eliminating Creatine Kinase–Myocardial Band Testing in Suspected Acute Coronary Syndrome: A Value-Based Quality Improvement (2017) (39)
- Biologic variation of a novel cardiac troponin I assay. (2011) (38)
- Depression as a risk factor for post-MI mortality. (2004) (38)
- 2007 universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay. (2010) (38)
- Patient Survival After Kidney Transplantation: Relationship to Pretransplant Cardiac Troponin T Levels (2009) (38)
- Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay. (2017) (38)
- Natriuretic peptides in heart failure. (2010) (38)
- Importance of low concentrations of cardiac troponins. (2006) (38)
- Association of B-Type Natriuretic Peptide With Survival in Patients With Degenerative Mitral Regurgitation. (2016) (38)
- Myocardial injury in severe COVID-19 infection (2020) (37)
- Abnormal technetium-99m pyrophosphate images in unstable angina: ischemia versus infarction? (1979) (37)
- PAPP-A as a marker of increased long-term risk in patients with chest pain. (2009) (37)
- Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma (1991) (37)
- Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data. (2020) (37)
- Specificity of a high-sensitivity cardiac troponin I assay using single-molecule-counting technology. (2009) (37)
- Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study. (2019) (36)
- High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes (2017) (36)
- Natriuretic Peptides and Analytical Barriers. (2017) (36)
- Troponin--past, present, and future. (2012) (36)
- A simplified method to predict occurrence of complete heart block during acute myocardial infarction. (1987) (35)
- Cardiovascular pharmacology. I. (1986) (35)
- The Definition of Myocardial Infarction (2010) (34)
- ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway (2017) (34)
- Soluble suppression of tumorigenicity 2 (sST2), but not galactin‐3, adds to prognostication in patients with systemic AL amyloidosis independent of NT‐proBNP and troponin T (2015) (34)
- Long-time quality assessment of the Elecsys Troponin T hs assay. (2013) (34)
- Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin (2017) (34)
- Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? (2017) (34)
- Third universal definition of myocardial infarction. (2013) (33)
- Cardiac Biomarkers (2015) (33)
- Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method. (2017) (33)
- Treatment of depression following acute myocardial infarction. (2002) (33)
- Platelet function testing in acute cardiac care – is there a role for prediction or prevention of stent thrombosis and bleeding? (2014) (33)
- Longitudinal studies of cardiac troponin I in a large cohort of healthy children. (2012) (33)
- Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure. (2016) (33)
- Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. (2015) (33)
- Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes. (2004) (32)
- Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation. (2011) (32)
- Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis (2017) (32)
- Cardiovascular biomarkers in patients with COVID-19 (2021) (32)
- Paucity of subtle myocardial injury after angioplasty delineated with MB CK. (1986) (31)
- Increase in creatine kinase MB isoenzyme levels after spinal surgery. (1994) (31)
- A study to derive a clinical decision rule for triage of emergency department patients with chest pain: design and methodology (2008) (31)
- Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study. (2018) (31)
- Expert Consensus Document. Third Universal Definition of Myocardial Infarction (2013) (30)
- Complications in Patients with Acute Myocardial Infarction Supported with Extracorporeal Membrane Oxygenation (2020) (30)
- Myocardial infarct extension: occurrence, outcome, and risk factors in the Multicenter Investigation of Limitation of Infarct Size. (1988) (30)
- Prompt detection of myocardial injury by assay of creatine kinase isoforms in initial plasma samples (1988) (30)
- Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience. (2012) (30)
- Left ventricular function and C-reactive protein levels in acute myocardial infarction. (2010) (30)
- Normal left ventricular performance in children with x‐linked hypophosphatemic rickets: A doppler echocardiography study (1990) (30)
- Cardiac Troponin T Before and After Kidney Transplantation: Determinants and Implications for Posttransplant Survival (2013) (29)
- New standard for the diagnosis of acute myocardial infarction. (2001) (29)
- Diagnostic concordance between NT-proBNP and BNP for suspected heart failure. (2018) (29)
- Reliability of Calculated Low-Density Lipoprotein Cholesterol. (2015) (29)
- Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. (2007) (28)
- Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure. (2013) (28)
- Cardiac magnetic resonance in patients with elevated troponin and normal coronary angiography (2019) (28)
- Sex and Gender Disparities in the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Older Adults. (2020) (28)
- Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population (2013) (28)
- High-sensitivity cardiac troponin: from theory to clinical practice. (2013) (28)
- Natriuretic Peptides to Predict Short-Term Mortality in Patients With Sepsis: A Systematic Review and Meta-analysis (2020) (27)
- Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naïve emergency department patients. (2006) (27)
- Effect of myocardial ischemia on cardiac troponin I and T. (2002) (27)
- gINTELLIGENCE EXPERT C ONSENSUS DOCUMENT Third Universal Definition of Myocardial Infarction (2012) (27)
- Atherosclerotic Cardiovascular Disease Risk Stratification Based on Measurements of Troponin and Coronary Artery Calcium. (2020) (27)
- Detection of reperfusion within 1 hour after coronary recanalisation by analysis of isoforms of the MM creatine kinase isoenzyme in plasma (1988) (27)
- Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. (2009) (26)
- Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB) (2019) (26)
- Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community. (2009) (26)
- Proenkephalin (PENK) as a Novel Biomarker for Kidney Function. (2017) (26)
- High sensitivity troponin in chest pain and acute coronary syndromes. A step forward? (2010) (26)
- The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. (2007) (26)
- Biomarker‐based risk prediction in the community (2016) (26)
- Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits. (2017) (25)
- Characterization in vivo of the fibrin specificity of activators of the fibrinolytic system. (1988) (25)
- Ruling-In Myocardial Injury and Ruling-Out Myocardial Infarction With the European Society of Cardiology 1-Hour Algorithm (2016) (25)
- Nature and time course of generation of creatine kinase, MB fraction in vivo☆ (1992) (25)
- Improved Assessment of Chest pain Trial (IMPACT): assessing patients with possible acute coronary syndromes (2017) (24)
- High-sensitivity cardiac troponin assays: isn't it time for equality? (2014) (24)
- Cardiovascular biomarkers: the state of the art in 2006. (2007) (24)
- Ninety-minute vs 3-h performance of high-sensitivity cardiac troponin assays for predicting hospitalization for acute coronary syndrome. (2013) (24)
- Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally? (2016) (24)
- Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm. (1985) (24)
- What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarification. (1995) (24)
- Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course. (1986) (24)
- High-Sensitivity Cardiac Troponin I Levels in Normal and Hypertensive Pregnancy. (2019) (23)
- Double porcine valve replacement in carcinoid heart disease. (1982) (23)
- Concordance of creatine kinase-MB activity and mass. (1989) (23)
- Smoking Behavior Postmyocardial Infarction Among ENRICHD Trial Participants: Cognitive Behavior Therapy Intervention for Depression and Low Perceived Social Support Compared With Care as Usual (2008) (23)
- Testing the wrong hypothesis: the failure to recognize the limitations of troponin assays. (2001) (23)
- Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging (2009) (23)
- Long-term prognosis of patients with clinical unstable angina pectoris without elevation of creatine kinase but with elevation of cardiac troponin i levels. (2002) (23)
- Variability Between Reagent Lots for High-Sensitivity Cardiac Troponin I May Affect Performance of Early Rule Out Strategies. (2017) (23)
- Screening for kidney disease in vascular patients: SCreening for Occult REnal Disease (SCORED) experience. (2009) (23)
- Myocardial infarction with normal coronary arteries: a role for MRI? (2007) (23)
- Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10years. (2017) (23)
- A small step for man, a leap forward for postoperative management. (2003) (23)
- Advantages of the lipoprotein-associated phospholipase A2 activity assay. (2016) (23)
- 'Paradox' of troponin elevations after non-cardiac surgery. (2015) (22)
- Dependence of plasmin-mediated degradation of platelet adhesive receptors on temperature and Ca2+. (1990) (22)
- Analytical performance of an immunoassay to measure proenkephalin. (2018) (22)
- Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay. (2007) (22)
- Biomarkers in heart failure: the importance of inconvenient details (2015) (22)
- A new simplified immediate prognostic risk score for patients with acute myocardial infarction (2006) (22)
- Unraveling N-terminal pro-B-type natriuretic peptide: another piece to a very complex puzzle in heart failure patients. (2015) (21)
- Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS). (1988) (21)
- Low high-sensitivity troponin I and zero coronary artery calcium score identifies coronary CT angiography candidates in whom further testing could be avoided. (2015) (21)
- Lack of elevation of platelet factor IV in plasma from patients with myocardial infarction. (1984) (21)
- Staging systems use for risk stratification of systemic amyloidosis in the era of high-sensitivity troponin T assay. (2019) (21)
- Erratum: Third universal definition of myocardial infarction (Journal of the American College of Cardiology (2012) 60 (158-98) DOI: 10.1016/j.jacc.2012. 08.001) (2013) (21)
- Evaluation of the Siemens ADVIA Centaur high-sensitivity cardiac troponin I assay in serum. (2018) (21)
- Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI. (2006) (21)
- Effect of Repeat Measurements of High-Sensitivity Cardiac Troponin on the Same Sample Using the European Society of Cardiology 0-Hour/1-Hour or 2-Hour Algorithms for Early Rule-Out and Rule-In for Myocardial Infarction. (2017) (21)
- Implementation of Clinical Decision Support Rules to Reduce Repeat Measurement of Serum Ionized Calcium, Serum Magnesium, and N-Terminal Pro-B-Type Natriuretic Peptide in Intensive Care Unit Inpatients. (2016) (21)
- Depression screening in patients with heart disease. (2009) (20)
- N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events from antiinflammatory drugs: a pilot trial. (2008) (20)
- A Non-classical Presentation of Tangier Disease with Three ABCA1 Mutations. (2012) (20)
- Relation of depression and mortality after myocardial infarction in women. (1991) (20)
- Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction (2020) (20)
- Weekend Effect in the Management and Outcomes of Acute Myocardial Infarction in the United States, 2000-2016 (2020) (20)
- Quantitative analysis for isoforms of creatine kinase MM in plasma by chromatofocusing, with on-line monitoring of enzyme activity. (1988) (20)
- Comparison of high‐sensitivity cardiac troponin I and T for the prediction of cardiac complications after non‐cardiac surgery (2018) (20)
- The prognostic impact of periprocedural myocardial infarction and injury (2018) (20)
- Men are different than women: it's true for cardiac troponin too. (2014) (19)
- High-Sensitivity Cardiac Troponin T Improves the Diagnosis of Perioperative MI (2017) (19)
- The third Universal Definition of Myocardial Infarction--moving forward. (2012) (19)
- The Universal Definition of Myocardial Infarction: Present and Future. (2020) (19)
- Decision support tool for early differential diagnosis of acute lung injury and cardiogenic pulmonary edema in medical critically ill patients. (2012) (19)
- Normal left ventricular performance documented by Doppler echocardiography in patients with long-standing hypocalcemia. (1989) (19)
- The IFCC Clinical Application of Cardiac Biomarkers Committee's Appraisal of the 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation: Getting Cardiac Troponin Right. (2020) (18)
- More rapid biochemical diagnosis of myocardial infarction: necessary? Prudent? Cost effective? (1993) (18)
- High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19 (2021) (18)
- Implications of the universal definition of myocardial infarction (2008) (18)
- Pregnancy-associated plasma protein A values in patients with stable cardiovascular disease: use of a new monoclonal antibody-based assay. (2011) (18)
- BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer. (2012) (18)
- High-sensitive cardiac troponin I (hs-cTnI) values in patients with stable cardiovascular disease: an initial foray. (2010) (18)
- Defining the Optimal Cardiac Troponin T Threshold for Predicting Death Caused by Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention (2014) (18)
- 2001--a biomarker odyssey. (1999) (18)
- Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Biomarkers. (2019) (17)
- Ceramide Scores Predict Cardiovascular Risk in the Community (2021) (17)
- TRAPID or Trapped? (2016) (17)
- Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity‐2 (2017) (17)
- Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide. (2009) (17)
- Fundamental concepts of effective troponin use: important principles for internists. (2015) (17)
- Variability of lipoprotein-associated phospholipase A2 measurements. (2008) (17)
- Elevations of troponin in patients with epileptic seizures? What do they mean? (2006) (16)
- Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm (2009) (16)
- Improving the 510(k) FDA process for cardiac troponin assays: in search of common ground. (2014) (16)
- Use of biomarkers in the emergency department and chest pain unit. (2005) (16)
- Nifedipine and acute myocardial infarction. (1981) (16)
- ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: A fond farewell at the retirement of CKMB. (2021) (16)
- Emerging biomarkers for acute heart conditions (2014) (15)
- Enzymatic estimation of the extent of irreversible myocardial injury early after reperfusion. (1989) (15)
- Nocturnal patterns of heart rate and the risk of mortality after acute myocardial infarction. (2014) (15)
- Altered circadian pattern of acute myocardial infarction in patients with depression (1991) (15)
- The use of antiarrhythmics in advanced cardiac life support. (1993) (15)
- High-sensitivity cardiac troponin T increases after stress echocardiography. (2019) (15)
- Ceramides Improve Atherosclerotic Cardiovascular Disease Risk Assessment beyond Standard Risk Factors. (2020) (15)
- Higher sensitivity troponin assays: Quo vadis? (2008) (15)
- Why we don't know the answer may be more important than the specific question. (2004) (15)
- Can Natriuretic Peptides be Used to Guide Therapy? (2016) (15)
- Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community. (2021) (15)
- New and old paradoxes. Acidosis and cardiopulmonary resuscitation. (1989) (15)
- Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States (2020) (14)
- Acute coronary syndromes in the community. (2015) (14)
- Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. (1983) (14)
- Adverse effects due to morphine sulfate. Challenge to previous clinical doctrine. (1985) (14)
- Time course of lysophosphatidylcholine release from ischemic human myocardium parallels the time course of early ischemic ventricular arrhythmia. (1997) (14)
- Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience (2021) (14)
- From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure. (2016) (14)
- Interpreting changes in troponin--clinical judgment is essential. (2012) (14)
- High‐Sensitivity Cardiac Troponin After Cardiac Stress Test: A Systematic Review and Meta‐Analysis (2019) (14)
- Treatment of prosthetic tricuspid valve thrombosis with low-dose tissue plasminogen activator. (1990) (14)
- 99th Percentile Upper-Reference Limit of Cardiac Troponin and the Diagnosis of Acute Myocardial Infarction. (2020) (14)
- Sample matrix and high-sensitivity cardiac troponin I assays (2019) (14)
- Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? (2008) (14)
- Aborted myocardial infarction: is it real in the troponin era? (2009) (14)
- Troponin elevations after electroconvulsive therapy: the need for caution. (2011) (14)
- A correlative study of cardiac biomarkers and left ventricular ejection fraction (LVEF) from N9831, a phase III randomized trial of chemotherapy and trastuzumab as adjuvant therapy for HER2-positive breast cancer (2007) (14)
- "Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. (2008) (14)
- Enhancement of metabolism of jeopardized myocardium by nifedipine. (1987) (14)
- Assessment of clinical performance without adequate analytical validation: A prescription for confusion. (2011) (14)
- Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. (2012) (14)
- Temporal Trends, Predictors, and Outcomes of Acute Ischemic Stroke in Acute Myocardial Infarction in the United States (2021) (14)
- Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing (2014) (13)
- Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. (2013) (13)
- Multicentre evaluation of a high sensitive Elecsys troponin T assay (2009) (13)
- Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular disease. (2014) (13)
- UTILITY OF EARLY MEASUREMENT OF PLASMA B TYPE NATRIURETIC PEPTIDE (BNP) IN THE ASSESSMENT OF ACUTE LUNG INJURY AND CARDIOGENIC PULMONARY EDEMA.: 78 (2005) (13)
- A case of floating gel. (2012) (13)
- ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties (2020) (13)
- Intervention to reduce inappropriate ionized calcium ordering practices: a quality-improvement project. (2015) (13)
- Evaluation of patients with possible cardiac chest pain: a way out of the jungle. (2012) (13)
- Key issues in the developing synergism between cardiovascular imaging and biomarkers. (2008) (13)
- Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial (2015) (12)
- Biochemical Validation of Patient-Reported Symptom Onset Time in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. (2015) (12)
- Detection of Unexpected Isoforms of Human Chorionic Gonadotropin by Qualitative Tests (12)
- Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study. (2016) (12)
- Performance characteristics of a high-sensitivity cardiac troponin assay using plasma and whole blood samples. (2017) (12)
- Prognostic implications of an early peak in plasma MB creatine kinase in patients with acute myocardial infarction. (1987) (12)
- Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes (2017) (12)
- Nighttime Heart Rate and Survival in Depressed Patients Post Acute Myocardial Infarction (2008) (12)
- High‐sensitivity cardiac troponin T in young, healthy adults undergoing non‐cardiac surgery (2017) (12)
- Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation. (2020) (11)
- Evaluation of a development version of the elecsys high sensitive troponin T assay (2008) (11)
- Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. (2005) (10)
- Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfalls. (1986) (10)
- Issues in early risk stratification for UA/NSTEMI (2001) (10)
- Implementing High-Sensitivity Cardiac Troponin T in a US Regional Healthcare System. (2020) (10)
- Unwinding the interaction of natriuretic peptides and neprilysin. (2015) (10)
- Ethical Issues in Cardiovascular Research Involving Humans (2009) (10)
- Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging (2015) (10)
- Comparison of novel pro-BNP(1-108) and standard BNP assays in heart failure patients. (2012) (10)
- Identification of myocardial injury in the emergency setting. (2010) (10)
- In search of specificity: The troponins* (1995) (10)
- The clinical impact of the universal diagnosis of myocardial infarction (2008) (10)
- Exercise tolerance in asymptomatic patients with moderate-severe valvular heart disease and preserved ejection fraction (2012) (10)
- Should apolipoprotein B replace LDL cholesterol as therapeutic targets are lowered? (2016) (10)
- Third universal definition of myocardial (2012) (10)
- Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). (2003) (9)
- In vivo assessment of thrombosis and fibrinolysis during acute myocardial infarction. (1987) (9)
- The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department. (2010) (9)
- High-sensitivity cardiac troponin assays: what analytical and clinical issues need to be addressed before introduction into clinical practice? Interview by Fred S. Apple. (2010) (9)
- Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. (2015) (9)
- MAJOR DEPRESSION AND SURVIVAL IN CONGESTIVE HEART FAILURE (1998) (9)
- Sensitive troponin I assay in patients with suspected acute coronary syndrome. (2011) (9)
- High-Sensitivity Troponin in Patients With Coronary Artery Endothelial Dysfunction. (2018) (8)
- Relationship of QRS scoring system to enzymatic and pathologic infarct size: the role of infarct location. (1988) (8)
- Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis (2016) (8)
- Corrigendum to: Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data. (2021) (8)
- Best Practices for Monitoring Cardiac Troponin in Detecting Myocardial Injury. (2017) (8)
- Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers. (2022) (8)
- Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis. (2020) (8)
- Release of cardiac troponin using a high sensitivity assay after exercise: Type 2 acute myocardial infarction? (2015) (8)
- Vascular versus myocardial dysfunction in acute coronary syndrome: are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification? (2008) (8)
- Cardiac procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data (2020) (8)
- Refining our criteria: a critical challenge. (2009) (8)
- Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritide. (2008) (7)
- Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure. (2014) (7)
- Canadian Institutes of Health Research dissemination grant on high-sensitivity cardiac troponin. (2014) (7)
- Using Biomarkers to Guide Heart Failure Therapy. (2017) (7)
- Hemodynamic effects of atrial interaction (1993) (7)
- High Sensitivity Cardiac Troponin Assays – How to Implement them Successfully (2016) (7)
- The Use of Intravenous Nitroglycerin in Cardiovascular Disease (1982) (7)
- High-Sensitivity Cardiac Troponin and Primary Prevention: An Important New Role. (2016) (7)
- Troponin, where do we go from here? (1997) (7)
- High-sensitivity troponin: where are we now and where do we go from here? (2014) (7)
- Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. (2014) (7)
- A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T (2011) (7)
- Rapid diagnosis of acute myocardial infarction. (1995) (7)
- Psychosocial adjustment of patients arriving early at the emergency department after acute myocardial infarction. (1992) (7)
- The biological basis of troponin in heart disease: possible uses for troponin fragmentology (2009) (7)
- Significance of elevated MB creatine kinase in patients after cardiac catheterization. (1984) (7)
- The spin stops here: inhibition of lipoprotein-associated phospholipase A2-- a promising target but a negative initial trial? (2009) (6)
- Copeptin to rule out myocardial infarction in Blacks versus Caucasians (2019) (6)
- Troponin Autoantibodies: From Assay Interferent to Mediator of Cardiotoxicity. (2017) (6)
- Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis. (2020) (6)
- Sex Disparities in Management and Outcomes of Cardiac Arrest Complicating Acute Myocardial Infarction in the United States. (2022) (6)
- Rate of disappearance of creatine kinase-MB after acute myocardial infarction: clinical determinants of variability. (1988) (6)
- Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. (2008) (6)
- Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure (2019) (6)
- Another Unanswerable Question∗ (2017) (6)
- New mechanisms of action for tissue-type plasminogen activator? (1986) (6)
- Sometimes earlier may not be better (2016) (6)
- Cardiovascular effects of diabetes (1989) (6)
- Biomarkers Associated with Progression of Diabetic Kidney Disease: Do They Hold the Same Meaning for Blacks and Women? (2018) (6)
- Cardiac function and brain-type natriuretic peptide in first-time flash pulmonary edema. (2008) (6)
- Racial Disparities in the Utilization and Outcomes of Temporary Mechanical Circulatory Support for Acute Myocardial Infarction-Cardiogenic Shock (2021) (6)
- Pacemaker lead perforation causing hemopericardium eight years after implantation. (2013) (6)
- Significance of High-Sensitivity Troponin T After Elective External Direct Current Cardioversion for Atrial Fibrillation or Atrial Flutter. (2018) (6)
- Comparing analytical outliers and the percent of emergency department patients with results above the 99th percentile upper reference limit for 2 conventional and one high sensitivity troponin assay. (2018) (6)
- Between-day versus within-day imprecision using the Abbott high-sensitivity cardiac troponin I assay at concentrations around 5 ng/l. (2019) (6)
- Markers in cardiology : a case-oriented approach (2007) (6)
- 1-h High-Sensitivity Troponin Rule-Out and Rule-In Approach: Strengths and Potential Weaknesses. (2018) (6)
- Degradation of Cardiac Troponins (2006) (6)
- Use of Cardiac Biomarkers for Detection of Myocarditis (2003) (5)
- Nature and time course of generation of isoforms of creatine kinase, MB fraction in vivo. (1992) (5)
- Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting. (2019) (5)
- Giant saphenous vein graft pseudoaneurysm: treatment with a vascular occlusion device. (2012) (5)
- Detecting myocardial infarction type 2: targetting the right patients (2017) (5)
- Management and outcomes of uncomplicated ST-segment elevation myocardial infarction patients transferred after fibrinolytic therapy. (2020) (5)
- High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain (2022) (5)
- Pre-analytical considerations in biomarker research: focus on cardiovascular disease (2021) (5)
- Science Moves Slowly. (2018) (5)
- Necessity of hospitalization and stress testing in low risk chest pain patients (2017) (5)
- Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction (2022) (5)
- Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation (2022) (5)
- Troponin T as a Predictor of End-Stage Renal Disease and All-Cause Death in African Americans and Whites From Hypertensive Families. (2015) (5)
- Influence of left ventricular filling pattern on exercise-induced changes of natriuretic peptides in patients with suspected coronary artery disease. (2008) (5)
- Abstract 4032: Lipoprotein-Associated Phospholipase A2 and Prognosis After Myocardial Infarction in a Geographically Defined Cohort (2006) (5)
- Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week. (2021) (5)
- Management of congestive heart failure in patients with acute myocardial infarction. (1986) (5)
- Clarifying the Proper Definitions for Type 2 Myocardial Infarction. (2018) (5)
- Sensitive cardiac troponin assays. (2009) (4)
- The Editor's Roundtable: major depression in patients with coronary heart disease. (2007) (4)
- Interpreting biomarkers during percutaneous coronary intervention: the need to reevaluate our approach. (2012) (4)
- The Gloomy Long-Term Prognosis of Patients With Type 2 Myocardial Infarction or Myocardial Injury. (2020) (4)
- High-Sensitivity Cardiac Troponin T in Prediction and Diagnosis of Myocardial Infarction and Long-Term Mortality after Non-Cardiac Surgery (2013) (4)
- Use of High-Sensitivity Cardiac Troponin in Patients With Chronic Comorbidities: Moving From Theory to Practice. (2018) (4)
- Use of intravenous diltiazem in patients with acute coronary artery disease. (1992) (4)
- Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United States. (2020) (4)
- Biomarker Tests for Risk Assessment in Coronary Artery Disease: Will They Change Clinical Practice? (2014) (4)
- Acute myocardial infarction: state of the art. (1986) (4)
- Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction (2011) (4)
- The clinical impact of circulating caspase-3 p17 level: a potential new biomarker for myocardial injury and cardiovascular disease. (2011) (4)
- Sex-Specific 99th Percentile URLs for Cardiac Troponin Assays-Their Time Has Come. (2020) (4)
- Complications of acute myocardial infarction. (1984) (4)
- Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction (2018) (4)
- Prognostic performance of high-sensitivity cardiac troponin T kinetic changes adjusted for elevated admission values and the GRACE score in an unselected emergency department population. (2014) (4)
- Intracranial Hemorrhage Complicating Acute Myocardial Infarction: An 18-Year National Study of Temporal Trends, Predictors, and Outcomes (2020) (4)
- Should myocardial infarction type 2 be regarded as two separate entities? (2019) (4)
- Conjoint use of MM and MB creatine kinase isoforms in detection of coronary recanalization. (1994) (4)
- Republished: Clinical implications of the Third Universal Definition of Myocardial Infarction (2014) (3)
- Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions. (2016) (3)
- Balloon aortic valvuloplasty under temporary mechanical circulatory support as a bridge to aortic valve replacement in a patient with hemodynamic failure secondary to critical aortic valve stenosis. (2012) (3)
- Intracoronary vs intravenous bivalirudin bolus in ST-elevation myocardial infarction patients treated with primary angioplasty (2016) (3)
- The Elevated High-Sensitivity Cardiac Troponin T Pilot: Diagnoses and Outcomes. (2021) (3)
- Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction. (2007) (3)
- Does cardiac rhythm monitoring in patients with elevated troponin levels lead to changes in management? (2017) (3)
- In Reply. (2017) (3)
- Letter by Sandoval et al Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction". (2019) (3)
- Biomarkers of vulnerable plaque: can better ways to quantitate Pregnancy-Associated Plasma Protein A (PAPP-A) help? (2012) (3)
- Can creatine kinase MB levels predict mortality after cardiac surgery? (2005) (3)
- Influence of Human Immunodeficiency Virus Infection on the Management and Outcomes of Acute Myocardial Infarction with Cardiogenic Shock. (2020) (3)
- COMPARISON OF CONVENTIONAL AND HIGH-SENSITIVITY TROPONIN IN PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH CHEST PAIN: A COLLABORATIVE META-ANALYSIS (2014) (3)
- Rapid rule-out of suspected acute coronary syndrome in the Emergency Department by high-sensitivity cardiac troponin T levels at presentation (2018) (3)
- High-sensitivity cardiac troponin assays--change is important. (2012) (3)
- Coronary thrombolysis: practical considerations. (1987) (3)
- Biomarkers in Acute Ischemic Heart Disease (2011) (3)
- Use of troponins in clinical practice: Evidence in favour of use of troponins in clinical practice (2019) (3)
- Biological variability of lipoprotein-associated phospholipase A2 activity in healthy individuals. (2017) (3)
- The value and limitations of cardiac enzymes in the recognition of acute myocardial infarction. (1993) (3)
- Myocarditis with ST elevation and elevated cardiac enzymes misdiagnosed as an ST-elevation myocardial infarction. (2012) (3)
- Cardiogenic Shock Complicating Non-ST-Segment Elevation Myocardial Infarction: An 18-Year Study. (2021) (3)
- Letter regarding article by Khan et al, "prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis". (2006) (3)
- Erratum: Troponin: The biomarker of choice for the detection of cardiac injury (Canadian Medical Association Journal (2005) 173, 10 (1191-1202)) (2006) (3)
- Multiplex protein assay performance/evaluation and the requirement for precision and correlation to clinical assays (2011) (3)
- Return-to-Play Guidelines for Athletes After COVID-19 Infection. (2020) (3)
- Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas à cause du BNP? (2019) (3)
- Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis (2013) (3)
- Another potential marker linking gender and cardiac mortality: PAPP-A--a new marker in risk stratification for women presenting with chest pain. (2009) (3)
- An enhanced ceramide-based approach for primary prevention of atherosclerotic events (2021) (3)
- Defining Myocardial Infarction (2006) (3)
- Use of low level high sensitivity troponin to rule out acute myocardial infarction in the emergency department (2010) (3)
- Another piece to the Troponin Puzzle: better confirmed, and with a path forward. (2013) (3)
- Lot-to-Lot Variation for Commercial High-Sensitivity Cardiac Troponin: Can We Realistically Report Down to the Assay's Limit of Detection? (2020) (3)
- Renal Dysfunction: How to Think About That in Acute Coronary Syndromes (2017) (2)
- Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically. (2020) (2)
- Plasma Ceramides Independently Predict Coronary Artery Disease and Major Adverse Cardiovascular Events (2016) (2)
- Meta-Analyses and Interpretation of Troponin Values in Heart Failure. (2018) (2)
- Panic disorder and depression in patients with chest pain not due to coronary artery disease. (1990) (2)
- Myocardial Injury in Critically III Patients-Reply (1995) (2)
- Are biomarkers the answer to the heart failure readmissions problem? (2013) (2)
- CENTRALIZED, STEPPED, PATIENT PREFERENCE-BASED TREATMENT FOR PATIENTS WITH POST-ACUTE CORONARY SYNDROME DEPRESSION: CODIACS VANGUARD RANDOMIZED CONTROL TRIAL (2013) (2)
- Exercise Capacity, NT-proBNP, and Exercise Hemodynamics in Adults Post-Fontan. (2023) (2)
- Galectin-3 Levels and Outcomes after Myocardial Infarction: A Community Study (2019) (2)
- Reply to letter by Trupp et al. (2017) (2)
- Analytical and Clinical Considerations in Implementing the Roche Elecsys Troponin T Gen 5 STAT Assay. (2021) (2)
- Erratum: Troponin release - Reversible or irreversible injury? Should we care? (Clinical Chemistry (2012) 58 (148-150) DOI: 10.1373/clinchem.2011.173070) (2012) (2)
- NT-proBNP in young healthy adults undergoing non-cardiac surgery. (2021) (2)
- Clinical Investigations Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure (2016) (2)
- Hemodynamic monitoring and pacing with one catheter: a pilot study. (1987) (2)
- Abstract 21588: Utilization of a High Sensitive Troponin T Assay Optimizes Serial Sampling in the Diagnosis of Acute Myocardial Infarction Compared to Multiple Contemporary Troponin Assays (2010) (2)
- Mortality in end stage heart failure is associated with paradoxically low NT-pro BNP and BNP levels: “natriuretic peptide exhaustion”? (2004) (2)
- Coronary angiography with a novel mobile radiographic imaging system (1992) (2)
- New potential uses for cardiac troponins. (2007) (2)
- Erratum: Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay (Journal of the American College of Cardiology (2011) 58 (1332-1339)) (2012) (2)
- Abstract 3608: Lipoprotein (a) Cholesterol, But Not Lp(a) Mass, Is An Independent Predictor Of Angiographic Coronary Artery Disease And Subsequent Cardiovascular Events In Patients Referred For Coronary Angiography. (2007) (2)
- Acute myocardial infarction due to fixed coronary artery stenosis from myocardial bridging. (2020) (2)
- Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the community (2021) (2)
- Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction. (2022) (2)
- Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol (2022) (2)
- Use and Prognostic Implications of Cardiac Troponin in COVID-19 (2022) (2)
- Adjusting the MI Codes Into the Framework of the Universal Definition of Myocardial Infarction. (2021) (2)
- ACTIVATION AND USEFULNESS OF PLASMA C-REACTIVE PROTEIN IN CALCIFIED AORTIC VALVE DISEASE (2014) (2)
- Peripheral blood monocyte subset assessment in non-ST-segment elevation myocardial infarction is required. (2010) (2)
- B-type natriuretic peptides in heart failure: update on clinical applications and limitations. (2007) (2)
- Role of BNP vs NT-proBNP Testing in the Age of New Drug Therapies: Sacubitril-Valsartan. (2019) (2)
- The Concentration of N-Terminal Pro–B-type Natriuretic Peptide Predicts the Risk of Cardiovascular Adverse Events from Antiinflammatory Drugs: A Pilot Trial (2008) (2)
- Causes of Death After Type 2 Myocardial Infarction and Myocardial Injury. (2021) (2)
- Lipoprotein(a) Cholesterol But Not Lipoprotein(a) Mass is Significantly Correlated with Angiographic Coronary Artery Disease and Major Adverse Events (2018) (2)
- Can amyotrophic lateral sclerosis chronically elevate troponin T (2015) (2)
- Digoxin therapy and mortality following confirmed or suspected myocardial infarction: Experience in the MILIS study (1986) (2)
- Prediction of Death After Noncardiac Surgery: Potential Advantage of Using High‐Sensitivity Troponin T as a Continuous Variable (2021) (2)
- Erratum: Biologic variation of a novel cardiac troponin I assay (Clinical Chemistry (2011) 57, (1080-1081) DOI: 10.1373/ clinchem.2011.162545) (2012) (2)
- Estimating Short- and Long-term Reference Change Values and Index of Individuality for Tests of Platelet Function. (2019) (2)
- It Will Take More Than Better Diagnostics to Improve the Care of Women With ACS. (2019) (2)
- Serial Measurements of Mid-Region-pro-ANP and C-Terminal pro-Vasopressin (Copeptin) and Relation to Troponin T in Ambulatory Chronic Heart Failure Patients – Is Synergism Important? (2010) (2)
- Troponin Using a High-Sensitivity Assay Rapid Exclusion of Acute Myocardial Infarction in Patients With Undetectable (2011) (1)
- Improved laboratory diagnosis (2000) (1)
- Vasospasm and type 2 AMI? (2015) (1)
- Biomarker and Invasive Hemodynamic Assessment of Cardiac Damage Class in Aortic Stenosis (2021) (1)
- Cardiac troponins and N-terminal pro-brain natriuretic peptide predict survival in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplant (2004) (1)
- High-Sensitivity Troponin in the Triage of Acute Decompensated Heart Failure. (2016) (1)
- Biomarker Testing Considerations in the Evaluation and Management of Patients with Heart Failure: Perspectives from the International Federation of Clinical Chemistry and Laboratory Medicine Committee. (2021) (1)
- Raising the Bar for Clinical Cardiac Troponin Research Studies and Implementation Science (2021) (1)
- Elevated serum troponin levels predict short-term mortality in patients with systemic amyloidosis (2003) (1)
- Natriuretic Peptides in Heart Failure Moderators : (2014) (1)
- Erratum: Elevated donor cardiac troponin I: A marker of acute graft failure in infant heart recipients (Circulation (1994) 90 (2618-2621)) (1995) (1)
- Incidence and significance of elevated lactate in the identification of critically ill patients (2012) (1)
- Implications of abnormal 99(m)Tc(Sn) pyrophosphate images in unstable angina-infarction versus ischemia (1978) (1)
- Type 1, Type 2 myocardial infarction and non-ischemic myocardial injury-opinion from the front lines. (2022) (1)
- High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias. (2023) (1)
- PLASMA CERAMIDE LEVELS ARE ELEVATED IN PATIENTS WITH EARLY CORONARY ATHEROSCLEROSIS AND MICROVASCULAR ENDOTHELIAL DYSFUNCTION (2021) (1)
- Influence of primary payer status on non-ST-segment elevation myocardial infarction: 18-year retrospective cohort national temporal trends, management and outcomes (2021) (1)
- Excellence in acute cardiac care: an overview of the seminar proceedings (2014) (1)
- Real-Time Detection of Analytical Outliers on the Roche Troponin T Generation 5 Assay (2019) (1)
- Chapter 39 The universal definition of myocardial infarction (2010) (1)
- COPEPTIN PROVIDES PROGNOSTIC VALUE IN PATIENTS WITH ACUTE CHEST PAIN (2014) (1)
- Cardiac biomarkers: Case studies and clinical correlations (2016) (1)
- Practice Guidelines : Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure (2007) (1)
- Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC Committee on Clinical Applications of Cardiac Bio-Markers (IFCC C-CB) (2023) (1)
- Early serial measurements of myeloperoxidase, a sensitive cardiac troponin I and high-sensitivity cardiac troponin T in patients presenting within 6 hours of chest pain onset (2012) (1)
- The Future: Interpreting New Guidelines for Myocardial Infarction (2008) (1)
- MYOCARDIAL INJURY IN CRITICALLY III PATIENTS. AUTHORS' REPLY (1995) (1)
- PLASMA CERAMIDE CONCENTRATIONS PREDICT RISK OF CARDIOVASCULAR EVENTS (2017) (1)
- RECONSIDERATION OF THE ROUTINE AND PREFERENTIAL USE OF LIDOCAINE IN THE EMERGENT TREATMENT OF VENTRICULAR ARRHYTHMIAS. AUTHOR REPLIES (1993) (1)
- Authors' response to Apple editorial. (2007) (1)
- Abstract 19365: Serial Changes in ST2 are Superior to Other Biomarkers in the Prediction of Adverse Events in a Cohort of Ambulatory Chronic Heart Failure Patients (2012) (1)
- Improving the 510k FDA Process for Cardiac Troponin Assays: In Search of Common Ground (2014) (1)
- The Biological Variability of Plasma Ceramides in Healthy Subjects. (2022) (1)
- Peri-operative myocardial infarction and high sensitive cardiac troponin: A start but by no means a finish (2012) (1)
- THE IMPACT OF CIRCULATING GALECTIN-3 LEVELS ON LONG-TERM OUTCOMES AFTER MYOCARDIAL INFARCTION IN THE COMMUNITY (2018) (1)
- Erratum: Patient survival after kidney transplantation: Relationship to pretransplant cardiac troponin T levels (American Journal of Transplantation (2009) 9 (1354-1361) DOI: 10.1111/j.1600-6143.2009.02636.x) (2014) (1)
- Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations (2022) (1)
- UTILITY OF ROUTINE SERUM FREE LIGHT CHAIN ASSAY FOR AMYLOIDOSIS IN PATIENTS WITH HEART FAILURE (2017) (1)
- The Utility of High Sensitivity Cardiac Troponin Among Patients with Immunoglobulin Light Chain Amyloidosis (2011) (1)
- Early detection of change in concentration by a research high sensitivity troponin I (hs-cTNI) assay and health outcomes at 30 days in a chest pain population (2010) (1)
- Prospective validation of a modified TIMI risk score in Emergency Department patients with chest pain and possible acute coronary syndromes (2010) (1)
- PROGNOSTIC SIGNIFICANCE OF AN ELEVATED CONVENTIONAL OR HIGH-SENSITIVITY CARDIAC TROPONIN IN PATIENTS WITH CHEST PAIN WITH AND WITHOUT A DIAGNOSIS OF MYOCARDIAL INFARCTION (2015) (1)
- New real-time two dimensional-assisted measurement of myocardial regional acoustic properties in the coronary care unit: On-line calculation and display of backscatter data (1991) (1)
- Troponins as early markers of acute myocardial infarction (1997) (1)
- Artificial intelligence-augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T. (2022) (1)
- Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in Uninsured Compared With Privately Insured Individuals (2022) (1)
- Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors. (2017) (1)
- Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications (2016) (1)
- Letter by Sandoval and Jaffe Regarding Article, "Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans". (2021) (1)
- Implementation of High-Sensitivity Cardiac Troponin Assays in the United States. (2022) (1)
- Serial Changes in Troponin I in COVID-19 Vaccine-Associated Myocarditis (2022) (1)
- Refining the Diagnosis of Type 2 Myocardial Infarction. (2017) (1)
- Response to Letter Regarding Article, “Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure: The Importance of Change Over Time” (2008) (1)
- Structural Cardiac Abnormalities in Patients with Atrial Fibrillation-Flutter and Myocardial Injury. (2022) (1)
- The use of biomarkers for acute cardiovascular disease (2018) (1)
- Correction: Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Measurement Below the Limit of Detection (2017) (1)
- Application of the fourth universal definition of myocardial infarction in clinical practice (2020) (1)
- A PROSPECTIVE EVALUATION OF THE EFFECT OF PULMONARY ARTERY CATHETERIZATION ON PATIENT MANAGEMENT (1983) (1)
- The impact of left ventricular hypertrophy on survival infarct size and ventricular function after myocardial infarction (1985) (1)
- Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome (2022) (1)
- REPRODUCIBILITY OF DYSRHYTHMIA FINDINGS BY A CENTRALIZED LABORATORY WITHIN A MAJOR MULTICENTER TRIAL. (1983) (1)
- TREATMENT OF DEPRESSION INCREASES HEART RATE VARIABILITY IN PATIENTS WITH CORONARY HEART DISEASE (1998) (1)
- COMPARISON OF THE RISK SCORES FOR DIAGNOSIS OF ACUTE CORONARY SYNDROMES IN PATIENTS WITH CHEST PAIN IN THE EMERGENCY ROOM (2023) (0)
- 924-117 Cardiac Injury in the Critically III: A Surprisingly Common Finding (1995) (0)
- Serial determination of troponin concentrations in the diagnosis of acute myocardial infarction (2009) (0)
- Disease Markers Cardiac Biomarkers (2015) (0)
- ONLINE EDUCATION SIGNIFICANTLY IMPROVED CARDIOLOGISTS’ AND EMERGENCY ROOM PHYSICIANS’ KNOWLEDGE OF THE USE OF HS-CTN ASSAYS (2022) (0)
- Discordantly elevated apolipoprotein B versus low-density lipoprotein cholesterol is associated with increased LP-PLA2 activity and poorer outcomes. (2017) (0)
- Abstract MP01: Vasopressin Contributes To Differences In The Physiology Of Hypertension Between Non-Hispanic Blacks And Whites (2020) (0)
- HIGH SENSITIVITY CARDIAC TROPONIN: NOT JUST HEART DISEASE (2020) (0)
- Biochemical markers of myocardial necrosis (2011) (0)
- High-Sensitivity Troponin: Revealing the Ominous Implications of Myocardial Injury in Critical Illness. (2021) (0)
- DO PATIENTS WITH ELEVATED TROPONINS REQUIRE TELEMETRY MONITORING (2015) (0)
- Pacing During Cardiac Arrest (2005) (0)
- Acute myocardial infarction and renal failure: impact of treatment on short and long-term survival (2002) (0)
- CAN A SECOND MEASUREMENT OF COPEPTIN IMPROVE ACUTE MYOCARDIAL INFARCTION RULE OUT (2014) (0)
- Sex differences in pregnancy associated plasma protein-A (PAPP-A) concentrations in patients with acute coronary syndromes (2008) (0)
- Are high-sensitivity cardiac troponin I values stable between preoperative visit and day of non-cardiac surgery? (2017) (0)
- Low-Density Lipoprotein Subfractionation: What Is the Role of the Lab When Reporting Discrepant Results? (2020) (0)
- Type 2 Myocardial Infarction: Do We Need Risk Scores? (2023) (0)
- How Good Does It Need to Be? (2016) (0)
- Caveat emptor. (2003) (0)
- A Risk Stratification Tool in Patients Presenting with Transient Ischemic Attack for Subsequent Acute Coronary Syndrome: The Thrombolysis in Myocardial Infarction Score (2007) (0)
- Thrombolytic therapy. (1993) (0)
- Is it possible to reduce time to appropriate treatment of acute coronary syndrome through a faster diagnosis? Focus on future innovative technologies and related treatments (2015) (0)
- Abstract 19711: Novel Insights and Reference Intervals of Soluble ST2 in a Pediatric Population Free of Heart Failure (2014) (0)
- Concentration of hs-Troponin in small cohort of transgender patients. (2022) (0)
- A Manifestation of Occult RlghtVentricular Infarction (2017) (0)
- The Need to Develop Clinical Guidance for the Use of High-Sensitivity Cardiac Troponin in Pediatric and Neonatal Patients. (2022) (0)
- Reply: To PMID 23395074. (2013) (0)
- Analytic result variation for high-sensitivity cardiac troponin: Interpretation and consequences. (2023) (0)
- Only Large Changes (>80%) in BNP Modify Risk in Patients with Chronic Heart Failure (2007) (0)
- Abstract 15775: The Impact of B-type Natriuretic Peptide Activation on the Association of Left Ventricular Longitudinal Strain With All-cause Mortality (2015) (0)
- Acute myocardial infarction: New management strategies edited by Jeffrey L. Anderson Aspen Publishers, Rockville (1987) 343 pages, illustrated, $42.00 ISBN: 0‐87 189‐397‐5 (1987) (0)
- Reproducibility of centralized laboratory interpretations of measures of myocardial infarct size, ventricular function, and ventricular electrical instability scintigraphy (1991) (0)
- Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation (2022) (0)
- Editorial Better Ways to Move Ahead (2015) (0)
- P1504Discordant low-density lipoprotein particle number versus low-density lipoprotein cholesterol is associated with increased C-reactive protein and poorer outcomes (2017) (0)
- Abstract 17219: Non-Invasive, Blood-Free Point of Care Test to Rapidly Exclude Myocardial Injury: The AI ECG (2020) (0)
- Concordanceof Creatine Kinase-MB Activityand Mass (2004) (0)
- Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol (2022) (0)
- Abstract P353: Survival after Acute Coronary Syndrome in the Community (2013) (0)
- Diagnostic and therapeutic implications: exploration through case discussions. (1992) (0)
- HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19 (2021) (0)
- Better ways to move ahead. (2015) (0)
- 24.16: Nuclear indices of myocardial infarction are significantly associated with troponin levels: A community-based study (2008) (0)
- Abstract 12196: ST2 Elevation in Myocardial Infarction - Associations With Cardiac Structure and Function (2016) (0)
- Corrigendum to "Measuring the contribution of Lp(a) cholesterol towards LDL-C interpretation" [Clin. Biochem. 86 (2020) 45-51]. (2020) (0)
- BIOMARKER MODEL FOR CORONARY ARTERY DISEASE (2016) (0)
- Terminology of acute coronary syndromes and definition of myocardial infarction (2011) (0)
- Syndrome: Systematic Review and Recommendations: A Scientific Statement From the Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary (2014) (0)
- Improving the Specificity of Cardiac Biomarkers-The Early Development of Cardiac Troponin I (cTnI) Assays. (2018) (0)
- SERIAL TROPONIN TESTING PROVIDES ADDITIONAL PROGNOSTIC INFORMATION IN PATIENTS HOSPITALIZED WITH COVID-19 (2023) (0)
- Artificial intelligence-enabled electrocardiographic algorithm for the detection of left ventricular dysfunction in emergency department patients undergoing high-sensitivity cardiac troponin T (2022) (0)
- Measuring Copeptin, a surrogate for Vasopressin in Patients with Hypertension - Can it identify those who are Volume Responsive? (2022) (0)
- Cardiac troponin I for assessment of pediatric cardiac injury (1995) (0)
- A prospective randomized study of nesiritide versus dobutamine in decompensated heart failure (PRESERVD-HF): design and preliminary data (2003) (0)
- Abstract 1204: Incidence of Myocardial Infarction: Impact of the Universal Definition in the Community (2008) (0)
- LACK OF MYOCARDIAL INJURY AFTER MAGNETIC RESONANCE IMAGING IN PATIENTS WITH CONDITIONAL AND NON-CONDITIONAL CARDIAC IMPLANTABLE ELECTRONIC DEVICES -A HIGH SENSITIVITY TROPONIN EVALUATION (2021) (0)
- Abstract P332: Thirty Day Readmissions After Myocardial Infarction in the Community (2012) (0)
- 60-year-old man with chest pain. (2004) (0)
- Thyrotropin in a Neonate Caused by a Maternally Transmitted (2006) (0)
- Biomarker Tests for Risk Assessment in Coronary Artery Disease: Will They Change Clinical Practice? (2013) (0)
- P3594Transition from 4th to 5th generation cardiac troponin T: testing patterns, myocardial infarction incident rates, and resource utilization across a multicenter United States regional healthcare system (2019) (0)
- 43 Etiology of Myocardial Ischemia in Emergency Department Chest Pain Patients With Two Negative Initial Troponins, Nonischemic ECG, and Nonconcerning Vital Signs (2017) (0)
- Abstract of original contributions: 40th Annual Scientific SessionConversion of MB creatine kinase isoforms in vivo (1991) (0)
- OBESITY IMPROVES LONG-TERM SURVIVAL IN PATIENTS WITH ATRIAL FIBRILLATION (2023) (0)
- Abstract P205: Comorbities Predict Future Hospitalization Risk in Incident Myocardial Infarction Survivors (2011) (0)
- Predictors of IIb/IIIa platelet antagonist use in an unselected registry of acute coronary syndrome patients (2003) (0)
- Copeptin Predicts Outcome in Patients with Severe Chronic Heart Failure (2008) (0)
- How to use high-sensitivity cardiac troponin assays in everyday clinical practice (2014) (0)
- 1137-94 Age and the lack af an adverse effect of diabetes explain the “obesity paradox” in patients with myocardial infarction (2004) (0)
- Ischemic heart disease as we move toward the 21st century (1999) (0)
- Abstract MP009: Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of ST2 (2017) (0)
- 1060-84 The impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in the registry of acute coronary syndrome (TRACS) (2004) (0)
- Diagnosis and prognosis of type 2 myocardial infarction using objective evidence of acute myocardial ischemia: a validation study. (2023) (0)
- High-sensitivity Troponin I Predicts Major Cardiovascular Events after Non-Cardiac Surgery: A Vascular Events in Non-Cardiac Surgery Patients Cohort Evaluation (VISION) Substudy. (2023) (0)
- Troponins and the Critically Ill Patient (2008) (0)
- Heart Valve Disease B-Type Natriuretic Peptide Clinical Activation in Aortic Stenosis Impact on Long-Term Survival (0)
- High-Sensitivity Cardiac Troponin Assays: What Analytical and Clinical Issues Need to Be Addressed before Introduction into Clinical Practice? (2010) (0)
- Application of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol at Low Levels (2016) (0)
- CAUSES OF ELEVATED HIGH SENSITIVITY TROPONIN T IN CONSECUTIVE EMERGENCY DEPARTMENT PATIENTS (2019) (0)
- for Biomarkers of Heart Failure Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues National Academy of Clinical Biochemistry and IFCC Committee for Standardization of (2013) (0)
- Interaction of Elevated Copeptin (CT-proVasopressin, a Surrogate Marker of Arginine Vasopressin), B-Type Natriuretic Peptide, and Hyponatremia in Predicting Outcome in Chronic Heart Failure (2011) (0)
- Erratum: Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure (Clinical Chemistry (2001) 51 (569-577)) (2005) (0)
- Abstract 20591: High-Sensitivity Cardiac Troponin After Cardiac Stress Test - A Meta-Analysis (2017) (0)
- Prognostic performance of rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population (2013) (0)
- Predictors of early mortality from an unselected patient registry of acute coronary syndromes (TRACS) (2003) (0)
- Mitral Valve Prolapse: A Consistent Manifestation (2005) (0)
- P6224Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery (2017) (0)
- Abstract 11602: Impact of Pre-Operative Type-B Natriuretic Peptide Level on Survival After Aortic Valve Replacement for Aortic Stenosis (2014) (0)
- PROGNOSTIC VALUE OF ST2 AFTER MYOCARDIAL INFARCTION (2016) (0)
- Abstract 26: Traditional Cardiac Risk Factors and Characteristics of the Cardiac History Are Associated With 30-Day Cardiac Events in Emergency Department Patients With Chest Pain (2010) (0)
- Biomarkers for Immune Checkpoint Inhibitor–Induced Myocarditis (2022) (0)
- Stimulus-induced analgesia and silent myocardial ischemia (1989) (0)
- Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers (2023) (0)
- Dobutamine administered early in the course of acute myocardial infarction (1979) (0)
- Comparative sensitivityof cardiactroponin I and lactate dehydrogenaseisoenzymesfor diagnosing acute myocardialinfarction (1996) (0)
- Corrigendum to "BD rapid serum tubes reduce false positive plasma troponin T results on the Roche Cobas e411 analyzer" [Clin. Biochem. 45, 10-11, July 2012, 842-844] (2013) (0)
- Prognostic Value of Serial Measurements of sST 2 and Galectin-3 in Ambulatory Chronic Heart Failure Patients (2015) (0)
- Table of Contents (2020) (0)
- Who is likely to survive cardiogenic shock (1982) (0)
- Infarto de miocardio de tipo 2. Revisión (2019) (0)
- CLINICAL IMPACT OF HIGH-SENSITIVITY CARDIAC TROPONIN T IMPLEMENTATION IN A UNITED STATES REGIONAL HEALTHCARE SYSTEM (2021) (0)
- Prognosis and cardiopulmonary resuscitation in elderly patients. (1994) (0)
- Chapter 33 The use of biomarkers for acute cardiovascular disease (2010) (0)
- International Cardiology Societies Collaborate on New MI Definition (2012) (0)
- Let the Buyer (Clinician) Beware. (2021) (0)
- UNSTABLE ANGINA IS NOT DEAD (2019) (0)
- WITHDRAWN: Corrigendum to "High-sensitive cardiac troponin I (hs-cTnl) values in patients with stable cardiovascular disease: An initial foray" [Clinica Chimica Acta 411 (2010) 812--817]. (2010) (0)
- An overview of clinical and laboratory issues affecting the laboratory measurement and reporting of troponin (2012) (0)
- JACC March 19,2003 ABSTRACTS - Cardiac Function and Heart Failure 197A (2016) (0)
- Abstract P362: Prognostic Value of Troponin in Myocardial Infarction in the Community (2011) (0)
- From Statistical Significance to Clinical Relevance: A Simple Algorithm to Integrate BNP and the Seattle Heart Failure Model for Risk Stratification in Heart Failure (2016) (0)
- Potential risks of non-cardiac peri-operative myocardial infarction/injury. (2023) (0)
- Abstract 18079: Targeted Use of Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure (2017) (0)
- SEX-SPECIFIC DIFFERENCES IN MORTALITY AND THE OBESITY PARADOX OF PATIENTS WITH ATRIAL FIBRILLATION (2023) (0)
- Comment New Mechanisms of Action for Tissue-Type Plasminogen Activator ? * (2010) (0)
- Detection of coronary clot lysis with an improved ELISA for cross-linked fibrin degradation products (1991) (0)
- MY APPROACH to cardiac troponin elevations in patients with renal disease. (2015) (0)
- Elevation of cardiac troponin T in patients with amyotrophic lateral sclerosis (2016) (0)
- The shocking lack of significant increases in high sensitivity troponin values after cardioversion (2020) (0)
- 1013-118 Impaired coronary microcirculation evidenced by abnormal thrombolysis in myocardial infarction frame counts in patients with transient left ventricular apical ballooning syndrome (2004) (0)
- Serial biomarker measurements in chronic heart failure (2008) (0)
- Rationale for the use of conjunctive anticoagulation during thrombolysis. (1996) (0)
- Abstract 16115: The Incidence of Acute Coronary Syndrome in the Community: 2005 to 2010 (2012) (0)
- CorrespondenceLetter to the EditorReply (2012) (0)
- What Is a Type 2 Myocardial Infarction: How Is It Recognized and What Should One Do to Establish That Diagnosis? (2016) (0)
- High-Sensitivity Troponin T Testing for Pediatric Patients in the Emergency Department (2021) (0)
- What will Change with Highly Sensitive Troponin Assays (2014) (0)
- SEVERE MAJOR DEPRESSION IS ASSOCIATED WITH DECREASED HEART RATE VARIABILITY IN CONGESTIVE HEART FAILURE (1998) (0)
- Low Level Troponin Interpretation In The Era Of High Sensitivity Troponins (2020) (0)
- Clinical evaluation of myocardial hypertrophy (1980) (0)
- The use of troponin measurements in patients with unstable angina. (1999) (0)
- Use of serum markers of myocardial injury for the early diagnosis of acute myocardial infarction (1996) (0)
- Chest discomfort, anxiety, and depression in patients with normal coronary arteriograms (1992) (0)
- President's Symposium: Expanding the Terrain of Psychosomatic Medicine: Seizing Opportunities for Growth ABSTRACTS Cardiovascular Disease II Paper Session TREATMENT OF DEPRESSION INCREASES HEART RATE VARIABILITY IN PATIENTS WITH CORONARY HEART DISEASE (2014) (0)
- Revisiting the definition of perioperative myocardial infarction after coronary artery bypass grafting. (2022) (0)
- Abstract 17152: Artificial Intelligence ECG for the Detection of Cardiac Injury as Confirmed by High Sensitivity Cardiac Troponin T-Concentrations (2020) (0)
- Identification and Management of Low Risk Patients Presenting to the Emergency Department with Chest Pain (2020) (0)
- Hospitalization of Low Risk Chest Pain Patients With Normal Troponin and Copeptin (2016) (0)
- A-067 The NT-proBNP level in Subclinical stage of cardiac structural or functional abnormalities among health checkups (2018) (0)
- Reply: Applying High-Sensitivity Cardiac Troponin T. (2021) (0)
- New AMI Guidelines (2008) (0)
- Association of Preoperative Growth Differentiation Factor-15 Concentrations and Postoperative Cardiovascular Events after Major Noncardiac Surgery (2023) (0)
- A novel approach to cardiac troponins to improve the diagnostic work-up in chest pain patients. (2012) (0)
- Professor Giora Landesberg, MD, DSc, MBA 1954 - 2021: A Physician and Research Pioneer in Perioperative Myocardial Infarction (2021) (0)
- *Effects of Icosapent Ethyl on Plasma Ceramides and Coronary Plaque Progression in EVAPORATE trial (2022) (0)
- Update on quality specifications for cardiac troponin assays (2014) (0)
- Chapter-05 Hypersensitive Troponins (2012) (0)
- Comparison of cytokine biomarker performance across immunoassay platforms (2011) (0)
- Abstract 13910: Importance of Non-invasive Estimates of Left Ventricular Filling Pressures in Critically Ill Patients (2020) (0)
- Incremental Prognostic Value of Semiautomated Left Ventricular Strain to BNP in Asymptomatic Aortic Stenosis. (2022) (0)
- Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction (2017) (0)
- Use and Prognostic Implications of Cardiac Troponin in COVID-19 (2023) (0)
- Use of Cardiac Troponin to Assist in the Management of Patients with Congestive Heart Failure: A Practical Guide (2018) (0)
- Comparison of angiogenic growth factors assays using a research mulitplex platform versus clinical platforms in patients with chest pain (2011) (0)
- What is the IMA assay really saying? (2005) (0)
- STRUCTURAL CARDIAC ABNORMALITIES IN PATIENTS WITH ATRIAL FIBRILLATION AND INCREASED HIGH SENSITIVITY CARDIAC TROPONIN VALUES (2021) (0)
- The retirement of CKMB. (2022) (0)
- 978-122 Ultra Exercise Induces Right Ventricular Dysfunction (1995) (0)
- Effects of diabetes on the heart Edited by Allan S. Jaffe (1992) (0)
- Comprar Markers in Cardiology | Jesse Adams | 9781405134187 | Blackwell Publishing (2007) (0)
- Discordantly Elevated Apolipoprotein B versus Low-Density Lipoprotein Cholesterol is Associated with Remnant Lipoproteins and Increased Cardiovascular Events (2021) (0)
- Does Copeptin Provide Additional Risk Stratification in Chest Pain Patients With a Mild Troponin Elevation (2014) (0)
- [Using troponins in the correct way]. (2007) (0)
- Concordance between mitral valve prolapse and abnormal collagen synthesis in phenotypically expressed and occult Ehlers Danlos syndrome (1980) (0)
- The Demise of Creatine Kinase-MB (2008) (0)
- Letter in response to "Use of preoperative cardiac troponin T to identify patients at risk for acute myocardial infraction and long-term mortality after major noncardiac surgery". (2014) (0)
- Comprar Management of Food Allergens | Jesse E. Adams | 9781405167581 | Wiley (2009) (0)
- LONG-TERM MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH MYOCARDIAL INJURY AND TYPE 1 AND 2 MYOCARDIAL INFARCTION (2022) (0)
- Ischemic Heart Disease in the Absence of Overt Coronary Artery Disease (2008) (0)
- New uses for nitroglycerin (1984) (0)
- 78-Year-Old Woman With Intermittent Chest Pain and Palpitations. (2019) (0)
- An interview with Allan S Jaffe: a life researching cardiac biomarkers. (2023) (0)
- MID-REGIONAL PROADRENOMEDULLIN PREDICTS LONG-TERM MORTALITY IN PATIENTS WITH CHEST PAIN (2014) (0)
- Cardiac Complications and Major Noncardiac Surgery. (2016) (0)
- Sex-Specific Thresholds for Cardiac Biomarkers—We Need to Move Forward (2023) (0)
- 1127-105 Transient left ventricular apical ballooning syndrome: A US case-series (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Allan S. Jaffe,?
Allan S. Jaffe, is affiliated with the following schools:
